Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Wiseone
    Junior Member
    • Apr 2010
    • 7

    #1

    De novo assembly strategy

    Hey all,
    I have been working with 98 million Illumina SE reads (RNA) and doing de novo assembly in CLC workbench. In my initial assembly I produced 170,000 contigs that I was able to identify using Blastx in Blast2GO. However, I have just received 40000 Sanger sequences from another researcher so I want to include these in the assembly to improve my 'transcriptome'. Does anyone have any advice on the optimal workflow for the assembly? Should I;

    1. Perform de novo assembly on the Illumina reads followed by a second assembly using the Illumina contigs and the Sanger reads.

    2. Perform one round of de novo assembly using the Illumina reads and Sanger reads?

    My goal is further improve the assembly using the STM pipeline (Optimization of de novo transcriptome assembly from next-generation sequencing data. 2010. Yann Surget-Groba and Juan I. Montoya-Burgos, Genome Research, 20: 1432-1440).

    Thanks!

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...